Jaclyn Wilkins, Senior Associate
Jaclyn is a commercial lawyer with a particular focus on games, digital media, sport, IT and Technology.
AboutJaclyn is a commercial lawyer who advises on a broad range of matters with a particular focus on IT and technology related agreements. Jaclyn also has considerable experience advising and representing a large cross-section of companies within the computer games industry ranging from start-up developers to large global publishers. She heads the firm’s computer games team. She provides advice on software development, licensing, publishing, hosting, support and maintenance agreements as well as general commercial agreements and associated issues including data protection, consumer and e-commerce legislation.
In addition, Jaclyn is involved in the firm’s sports sector, with specific expertise in eSports. She advises on commercial rights deals, including sponsorship, licensing, media rights and endorsement agreements, as well as giving regulatory advice to organisations in the sector.
Jaclyn is admitted to practise in England and Wales.
- Acting for a large MMORPG publisher on a range of matters connected with the development and launch of its games including middleware licensing, distribution agreements, data protection and consumer law issues
- Advising an independent developer of children’s games on terms and conditions for prize draws and competitions and on the relevant laws (including consumer and data protection laws) regarding dealing with children
- Acting for a large German publisher on a range of licensing and publishing agreements
- Representing a number of independent software companies on the licensing of specialist financial services software into large international banks
Charles Russell Speechlys advises Jensen Hughes on the acquisition of leading forensic investigations firm IFIC
Charles Russell Speechlys has advised Jensen Hughes on the acquisition of a leading forensic investigator in the UK and Ireland markets.
Charles Russell Speechlys advises Apposite Capital on their investment into Mirada Medical
Mirada is a leading AI software developer for streamlining cancer treatment planning applications.